CBRE GROUP INC - A (CBRE)

US12504L1098 - Common Stock

86.32  -0.29 (-0.33%)

After market: 86.32 0 (0%)

Fundamental Rating

5

Taking everything into account, CBRE scores 5 out of 10 in our fundamental rating. CBRE was compared to 66 industry peers in the Real Estate Management & Development industry. CBRE has only an average score on both its financial health and profitability. CBRE is not valued too expensively and it also shows a decent growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year CBRE was profitable.
CBRE had a positive operating cash flow in the past year.
CBRE had positive earnings in each of the past 5 years.
In the past 5 years CBRE always reported a positive cash flow from operatings.

1.2 Ratios

CBRE's Return On Assets of 4.37% is amongst the best of the industry. CBRE outperforms 89.23% of its industry peers.
CBRE has a better Return On Equity (11.93%) than 92.31% of its industry peers.
CBRE has a better Return On Invested Capital (6.05%) than 92.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBRE is above the industry average of 5.28%.
Industry RankSector Rank
ROA 4.37%
ROE 11.93%
ROIC 6.05%
ROA(3y)6.52%
ROA(5y)6.33%
ROE(3y)17.13%
ROE(5y)16.52%
ROIC(3y)7.76%
ROIC(5y)8.08%

1.3 Margins

CBRE's Profit Margin of 3.09% is fine compared to the rest of the industry. CBRE outperforms 70.77% of its industry peers.
In the last couple of years the Profit Margin of CBRE has declined.
CBRE's Operating Margin of 3.41% is fine compared to the rest of the industry. CBRE outperforms 69.23% of its industry peers.
In the last couple of years the Operating Margin of CBRE has declined.
Looking at the Gross Margin, with a value of 19.64%, CBRE is in line with its industry, outperforming 49.23% of the companies in the same industry.
In the last couple of years the Gross Margin of CBRE has declined.
Industry RankSector Rank
OM 3.41%
PM (TTM) 3.09%
GM 19.64%
OM growth 3Y-6.92%
OM growth 5Y-7.46%
PM growth 3Y-0.75%
PM growth 5Y-9.13%
GM growth 3Y-0.84%
GM growth 5Y-2.89%

5

2. Health

2.1 Basic Checks

CBRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CBRE has been reduced compared to 1 year ago.
CBRE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBRE has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.34 indicates that CBRE is not in any danger for bankruptcy at the moment.
CBRE has a better Altman-Z score (3.34) than 80.00% of its industry peers.
CBRE has a debt to FCF ratio of 20.59. This is a negative value and a sign of low solvency as CBRE would need 20.59 years to pay back of all of its debts.
CBRE's Debt to FCF ratio of 20.59 is fine compared to the rest of the industry. CBRE outperforms 63.08% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that CBRE is not too dependend on debt financing.
CBRE's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. CBRE outperforms 52.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 20.59
Altman-Z 3.34
ROIC/WACC0.69
WACC8.77%

2.3 Liquidity

CBRE has a Current Ratio of 1.17. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
CBRE has a Current ratio of 1.17. This is in the lower half of the industry: CBRE underperforms 63.08% of its industry peers.
CBRE has a Quick Ratio of 1.17. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.17, CBRE perfoms like the industry average, outperforming 43.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17

5

3. Growth

3.1 Past

CBRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.39%.
CBRE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.20% yearly.
Looking at the last year, CBRE shows a small growth in Revenue. The Revenue has grown by 3.64% in the last year.
The Revenue has been growing by 8.41% on average over the past years. This is quite good.
EPS 1Y (TTM)-32.39%
EPS 3Y5.39%
EPS 5Y3.2%
EPS growth Q2Q3.76%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y10.27%
Revenue growth 5Y8.41%
Revenue growth Q2Q9.22%

3.2 Future

CBRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.57% yearly.
Based on estimates for the next years, CBRE will show a quite strong growth in Revenue. The Revenue will grow by 9.02% on average per year.
EPS Next Y15.96%
EPS Next 2Y20.99%
EPS Next 3Y21.4%
EPS Next 5Y19.57%
Revenue Next Year11.9%
Revenue Next 2Y10.44%
Revenue Next 3Y8.97%
Revenue Next 5Y9.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.48, CBRE is valued on the expensive side.
CBRE's Price/Earnings ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 78.46% of the companies in the same industry.
CBRE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.02.
Based on the Price/Forward Earnings ratio of 19.38, the valuation of CBRE can be described as rather expensive.
CBRE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CBRE is cheaper than 83.08% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.58, CBRE is valued at the same level.
Industry RankSector Rank
PE 22.48
Fwd PE 19.38

4.2 Price Multiples

78.46% of the companies in the same industry are more expensive than CBRE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBRE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 151.41
EV/EBITDA 16.5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CBRE may justify a higher PE ratio.
A more expensive valuation may be justified as CBRE's earnings are expected to grow with 21.40% in the coming years.
PEG (NY)1.41
PEG (5Y)7.02
EPS Next 2Y20.99%
EPS Next 3Y21.4%

0

5. Dividend

5.1 Amount

CBRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBRE GROUP INC - A

NYSE:CBRE (5/6/2024, 7:04:00 PM)

After market: 86.32 0 (0%)

86.32

-0.29 (-0.33%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap26.50B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 22.48
Fwd PE 19.38
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.41
PEG (5Y)7.02
Profitability
Industry RankSector Rank
ROA 4.37%
ROE 11.93%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.41%
PM (TTM) 3.09%
GM 19.64%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-32.39%
EPS 3Y5.39%
EPS 5Y
EPS growth Q2Q
EPS Next Y15.96%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.64%
Revenue growth 3Y10.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y